Trials / Completed
CompletedNCT00774904
Adiponectin and Insulin Resistance in Diabetic Nephropathy
Adiponectin is Positively Associated With Insulin Resistance in Subjects With Type 2 Diabetic Nephropathy and Effects by Angiotensin Type 1 Receptor Blocker Losartan
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Xi'an Jiaotong University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Plasma adiponectin concentration is inversely associated with renal function. There is little literature on adiponectin levels and regulation by antihypertensive medication with an angiotensin II-receptor blocker (ARB), especially in subjects with type 2 diabetes in different stage of chronic kidney disease (CKD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Losartan | Angiotensin II Type 1 Receptor Blockers |
Timeline
- Start date
- 2007-04-01
- Primary completion
- 2007-10-01
- Completion
- 2007-11-01
- First posted
- 2008-10-17
- Last updated
- 2008-10-20
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT00774904. Inclusion in this directory is not an endorsement.